Spots Global Cancer Trial Database for Clinical Trial for Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical Trial for Prostate Cancer
Official Title:
Study ID: NCT00076531
Conditions
Prostate Cancer
Interventions
Leuprolide Acetate for Injectable Suspension 22.5 mg
Study Description
Brief Summary: Phase III trial using an injectable for treatment of prostate cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Contact Details
Name: James A. Page, M.D.
Affiliation: Oakwood Laboratories, LLC
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
